Bove Mauro 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Jul 19, 2018
Insider Transaction Report
Form 4
Bove Mauro
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-07-17$0.21/sh+200,000$42,000→ 325,000 totalExercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying)
Holdings
- 125,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The option vests in four equal annual installments beginning on September 1, 2017.
- [F2]The option vests in four equal installments of 50,000 shares on each of July 17, 2018, 2019, 2020 and 2021.